₹506.40
+1.92%NSE close, 16 Nov 2026
+24.82%
Sai Parenterals is a small cap company, listed on NSE under the symbol SAIPARENT. At ₹506.40 a share, the market values the whole company at ₹2,237 crore.
In FY26, it reported sales of ₹381 crore and a net profit of ₹14 crore, an operating margin of 10.2%.
The market values the company at 89.7 times its profit over the last twelve months and 4.51 times its book value; its return on equity is 5.0% and its borrowings are 0.72 times its equity.
Promoters hold 51.16% of the shares. Foreign institutions hold 2.85%, and domestic institutions, mutual funds among them, 7.84%.
₹ crore. Consolidated figures.
Transcript
Link of Recording
| 13.2% |
| 13.2% |
| 20.6% |
| Other income | 3.1 | 2.9 | 3.7 | 3.7 |
|---|
| Interest | 5.4 | 8.4 | 9.4 | 9.0 |
|---|
| Depreciation | 5.8 | 8.2 | 8.1 | 25.1 |
|---|
| Profit before tax | −11.6 | 12.4 | 9.8 | 9.9 |
|---|
| Tax | −5.0 | −0.8 | 1.9 | −0.6 |
|---|
| Net profit | −6.7 | 13.2 | 7.9 | 10.5 |
|---|
| EPS (₹) | -2.22 | 4.02 | 1.79 | 2.38 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 381 |
| Expenses | 342 |
| Operating profit | 38.7 |
| Operating margin | 10.2% |
| Other income | 8.5 |
| Interest | 18.4 |
| Depreciation | 16.9 |
| Profit before tax | 11.9 |
| Tax | −2.3 |
| Net profit | 14.3 |
| EPS (₹) | 4.36 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 93.1 | −205 |
| From investing | −274 | −69.8 |
| From financing | 596 | −12.3 |
| Spent on fixed assets | −18.3 | −49.6 |
| Free cash flow | 74.8 | −255 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 3.7% |
| Operating margin | 10.2% |
| Return on equity | 2.9% |
| Return on capital employed | 3.7% |
| Return on assets | 1.0% |
| Debt to equity | 0.65 |
| Interest coverage | 1.60 |
| Debt to assets | 0.22 |
| Current ratio | 1.44 |
| Quick ratio | 1.14 |
| Cash ratio | 0.73 |
| Asset turnover | 0.27 |
| Fixed asset turnover | 6.18 |
| Inventory turnover | 1.40 |
| Receivables turnover | 2.10 |
| Gross margin | 36.4% |
| Cash from operations to profit | 653.0% |
The financial results for the period ended September 30, 2026.
Schedule of meet
Sai Parenterals Completes the Acquisition of R&D Facility Prathyak Laboratories
Monitoring agency report for the quarter ended 30 June 2026
Schedule of meet
Outcome of Board Meeting held on September 30, 2026.